Related Experiment Video

Updated: Feb 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K

Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease

Hassan Allaqaband1, David D Gutterman1,2,3,4, Andrew O Kadlec1,2,3

  • 1Cardiovascular Center, Medical College of Wisconsin , Milwaukee, Wisconsin.

Physiology (Bethesda, Md.)
|August 16, 2018
PubMed

Insights

Coronary artery disease research often overlooks microcirculatory dysfunction, a key predictor of cardiovascular events. This review explores diagnosing and treating this small vessel issue, vital for improving patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Medical Research

Background:

  • Current coronary artery disease (CAD) treatments primarily target large epicardial vessels.
  • Microcirculatory dysfunction in the heart is a significant predictor of adverse cardiovascular events.
  • Limited research exists on in vivo diagnosis and therapeutic interventions for coronary microcirculation.

Purpose of the Study:

  • To review the pathophysiology of coronary arteriolar dysfunction.
  • To define the prognostic implications of microcirculatory dysfunction.
  • To evaluate current diagnostic modalities and explore potential therapeutic strategies for coronary microcirculation.

Main Methods:

  • Literature review of pathophysiology, prognosis, diagnostics, and therapeutics for coronary microcirculatory dysfunction.
  • Analysis of existing diagnostic techniques.
  • Speculation on current and future therapeutic interventions.

Main Results:

  • Coronary microcirculatory dysfunction is a critical, yet understudied, aspect of CAD.
  • Existing diagnostic tools for epicardial vessels are insufficient for microcirculation.
  • Therapeutic options for improving microcirculatory function are limited but evolving.

Conclusions:

  • There is a critical need to shift focus towards diagnosing and treating coronary microcirculatory dysfunction.
  • Advancements in diagnostic and therapeutic strategies are essential for comprehensive CAD management.
  • Further research is required to fully understand and address the impact of microcirculatory dysfunction on cardiovascular health.

More Related Videos

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma06:40

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma

Published on: March 11, 2022

4.3K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

952

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
576
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703